ZimVie Inc. has been fully acquired by ARCHIMED, an investment firm focused on healthcare industries. The transaction was completed at $19.00 per share, resulting in ZimVie being delisted from NASDAQ.

ZimVie Inc. has been fully acquired by ARCHIMED for $19.00 per share, delisting the company from NASDAQ. The transaction represents a strategic move in the dental implant market.

ZimVie stockholders have voted to approve the acquisition by ARCHIMED, with the merger expected to close on October 20, 2025, subject to meeting all agreement conditions.

Law firm investigating potential securities law violations and fiduciary duty breaches for ZimVie, Aris Water Solutions, and scPharmaceuticals regarding their proposed sales and merger transactions.

Law firm investigating potential securities law violations and fiduciary duty breaches for multiple companies undergoing mergers or acquisitions.